SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007; 18: 827-834.
  • 2
    Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009; 27: 6237-6242.
  • 3
    Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003; 21: 4560-4567.
  • 4
    Nonaka D, Kusamura S, Baratti D, et al. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution. Cancer. 2005; 104: 2181-2188.
  • 5
    Yan TD, Brun E, Carlos A, et al. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2007; 14: 41-49.
  • 6
    Sugarbaker PH: Peritonectomy procedures. Ann Surg. 1995; 221: 29-42.
  • 7
    Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treatment Res. 1996; 82: 359-374.
  • 8
    Manzini Vde P, Recchia L, Cafferata M, et al. Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol. 2010; 21: 348-353.
  • 9
    Weiss SW. World Health Organization, International Histological Classification of Tumors. Histological typing of soft tissue tumors, 2nd ed. Berlin: Springer-Verlag, 1994.
  • 10
    Goldblum J, Hart WR. Localized and diffuse mesotheliomas of genital tract and peritoneum of women. Am J Surg Pathol. 1995; 19: 1124-1137.
  • 11
    Kerrigan SA, Turrnir RT, Clement PB, Young RH, Churg A. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer. 2002; 94: 378-385.
  • 12
    Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer. 2005; 103: 839-849.
  • 13
    EdgeSB, ByrdDR, ComptonCC, FritzAG, GreeneFL, TrottiA, editors. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer, 2010.
  • 14
    Swellengrebel HA, Zoetmulder FA, Smeenk RM, Antonini N, Verwaal VJ. Quantitative intra-operative assessment of peritoneal carcinomatosis—a comparison of three prognostic tools. Eur J Surg Oncol. 2009; 35: 1078-1084.
  • 15
    Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010; 28: 63-68.
  • 16
    Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer—12-year single center experience. Eur J Surg Oncol. 2009; 35: 1186-1191.
  • 17
    Yan TD, Morris DL, Shigeki K, Dario B, Marcello D. Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol. 2008; 98: 224-227.
  • 18
    Yan TD, Yoo D, Sugarbaker P. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006; 32: 948-953.
  • 19
    Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M. Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2010; 17: 45-53.